The role of immunity and inflammation in lung senescence and susceptibility to infection in the elderly

Seminars in Respiratory and Critical Care Medicine

Volumn 31, Issue 5, 2010, Pages 561-574

  Meyer, Keith C ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

aged; aging; elderly; immunity; immunosenescence; Lung; pneumonia

Indexed keywords

AMANTADINE; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; INFLUENZA VACCINE; OSELTAMIVIR; PNEUMOCOCCUS VACCINE; RIMANTADINE; SIALIDASE INHIBITOR; ZANAMIVIR;

ADAPTIVE IMMUNITY; AGED; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; HUMAN; IMMUNE RESPONSE; INFECTION SENSITIVITY; INFLUENZA; INFLUENZA B; INNATE IMMUNITY; LOWER RESPIRATORY TRACT INFECTION; LUNG INFECTION; LUNG LAVAGE; NONHUMAN; PNEUMOCOCCAL INFECTION; PNEUMONIA; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SENESCENCE;

AGED; AGING; DISEASE SUSCEPTIBILITY; HUMANS; IMMUNE SYSTEM; LUNG; RESPIRATORY TRACT INFECTIONS;

EID: 77958148045     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0030-1265897     Document Type: Review

References (163)

1. Pawelec G, Larbi A. Immunity and ageing in man: Annual Review 2006/2007. Exp Gerontol 2008 43 34-38
2. Hasler P, Zouali M. Immune receptor signaling, aging, and autoimmunity. Cell Immunol 2005 233 102-108
3. Meyer K C. Aging. Proc Am Thorac Soc 2005 2 433-439
4. Franceschi C, Bonafè M, Valensin S. Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine 2000 18 1717-1720
5. Franceschi C, Bonafè M. Centenarians as a model for healthy aging. Biochem Soc Trans 2003 31 457-461
6. Franceschi C, Monti D, Sansoni P, Cossarizza A. The immunology of exceptional individuals: the lesson of centenarians. Immunol Today 1995 16 12-16
7. Meyer K C. The aging human lung: age-associated changes in structure and function In: Conn PM Handbook of Models for Human Aging. Boston, MA Elsevier Academic 2006 727-734
8. Thompson A B., Scholer S G., Daughton D M., Potter J F., Rennard S I. Altered epithelial lining fluid parameters in old normal individuals. J Gerontol 1992 47 M171-M176
9. Meyer K C., Ershler W, Rosenthal N S., Lu X G., Peterson K. Immune dysregulation in the aging human lung. Am J Respir Crit Care Med 1996 153 1072-1079
10. Meyer K C., Rosenthal N S., Soergel P, Peterson K. Neutrophils and low-grade inflammation in the seemingly normal aging human lung. Mech Ageing Dev 1998 104 169-181
11. Meyer K C., Soergel P. Variation of bronchoalveolar lymphocyte phenotypes with age in the physiologically normal human lung. Thorax 1999 54 697-700
12. Meyer K C., Cardoni A, Xiang Z Z. Vascular endothelial growth factor in bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease. J Lab Clin Med 2000 135 332-338
13. Harms K L., Chen X. Histone deacetylase 2 modulates p53 transcriptional activities through regulation of p53-DNA binding activity. Cancer Res 2007 67 3145-3152
14. Delves P J., Roitt I M. The immune system: first of two parts. N Engl J Med 2000 343 37-49
15. Delves P J., Roitt I M. The immune system: second of two parts. N Engl J Med 2000 343 108-117
16. Medzhitov R, Janeway C J. Jr. Innate immunity. N Engl J Med 2000 343 338-344
17. Monie T P., Bryant C E., Gay N J. Activating immunity: lessons from the TLRs and NLRs. Trends Biochem Sci 2009 34 553-561
18. Medzhitov R, Janeway C Jr. Innate immune recognition: mechanisms and pathways. Immunol Rev 2000 173 89-97
19. Zhang P, Summer W R., Bagby G J., Nelson S. Innate immunity and pulmonary host defense. Immunol Rev 2000 173 39-51
20. Corberand J, Ngyen F, Laharrague P et al. Polymorphonuclear functions and aging in humans. J Am Geriatr Soc 1981 29 391-397
21. Fu Y K., Arkins S, Li Y M., Dantzer R, Kelley K W. Reduction in superoxide anion secretion and bactericidal activity of neutrophils from aged rats: reversal by the combination of gamma interferon and growth hormone. Infect Immun 1994 62 1-8
22. Tortorella C, Ottolenghi A, Pugliese P, Jirillo E, Antonaci S. Relationship between respiratory burst and adhesiveness capacity in elderly polymorphonuclear cells. Mech Ageing Dev 1993 69 53-63
23. Fülöp T Jr, Fouquet C, Allaire P et al. Changes in apoptosis of human polymorphonuclear granulocytes with aging. Mech Ageing Dev 1997 96 15-34
24. Tortorella C, Piazzolla G, Spaccavento F, Pece S, Jirillo E, Antonaci S. Spontaneous and Fas-induced apoptotic cell death in aged neutrophils. J Clin Immunol 1998 18 321-329
25. Szakal A K., Kapasi Z F., Masuda A, Tew J G. Follicular dendritic cells in the alternative antigen transport pathway: microenvironment, cellular events, age and retrovirus related alterations. Semin Immunol 1992 4 257-265
26. Pietschmann P, Hahn P, Kudlacek S, Thomas R, Peterlik M. Surface markers and transendothelial migration of dendritic cells from elderly subjects. Exp Gerontol 2000 35 213-224
27. Steger M M., Maczek C, Grubeck-Loebenstein B. Morphologically and functionally intact dendritic cells can be derived from the peripheral blood of aged individuals. Clin Exp Immunol 1996 105 544-550
28. Lung T L., Saurwein-Teissl M, Parson W, Schönitzer D, Grubeck-Loebenstein B. Unimpaired dendritic cells can be derived from monocytes in old age and can mobilize residual function in senescent T cells. Vaccine 2000 18 1606-1612
29. Shodell M, Siegal F P. Circulating, interferon-producing plasmacytoid dendritic cells decline during human ageing. Scand J Immunol 2002 56 518-521
30. Davila D R., Edwards C K. III, Arkins S, Simon J, Kelley K W. Interferon-gamma-induced priming for secretion of superoxide anion and tumor necrosis factor-alpha declines in macrophages from aged rats. FASEB J 1990 4 2906-2911
31. Alvarez E, Machado A, Sobrino F, Santa Maria C. Nitric oxide and superoxide anion production decrease with age in resident and activated rat peritoneal macrophages. Cell Immunol 1996 169 152-155
32. Lavie L, Weinreb O, Gershon D. Age-related alterations in superoxide anion generation in mouse peritoneal macrophages studied by repeated stimulations and heat shock treatment. J Cell Physiol 1992 152 382-388
33. Khare P D., Dhawan R, Chaturvedi U C. Identification and characterization of receptor for dengue virus-induced macrophage cytotoxin. Indian J Exp Biol 1996 34 652-657
34. Chen L C., Pace J L., Russell S W., Morrison D C. Altered regulation of inducible nitric oxide synthase expression in macrophages from senescent mice. Infect Immun 1996 64 4288-4298
35. Renshaw M, Rockwell J, Engleman C, Gewirtz A, Katz J, Sambhara S. Cutting edge: impaired Toll-like receptor expression and function in aging. J Immunol 2002 169 4697-4701
36. Boehmer E D., Goral J, Faunce D E., Kovacs E J. Age-dependent decrease in Toll-like receptor 4-mediated proinflammatory cytokine production and mitogen-activated protein kinase expression. J Leukoc Biol 2004 75 342-349
37. Swift M E., Burns A L., Gray K L., DiPietro L A. Age-related alterations in the inflammatory response to dermal injury. J Invest Dermatol 2001 117 1027-1035
38. Ashcroft G S., Horan M A., Ferguson M W. Aging alters the inflammatory and endothelial cell adhesion molecule profiles during human cutaneous wound healing. Lab Invest 1998 78 47-58
39. McNerlan S E., Rea I M., Alexander H D., Morris T C. Changes in natural killer cells, the CD57CD8 subset, and related cytokines in healthy aging. J Clin Immunol 1998 18 31-38
40. Ogata K, Yokose N, Tamura H et al. Natural killer cells in the late decades of human life. Clin Immunol Immunopathol 1997 84 269-275
41. Miyaji C, Watanabe H, Toma H et al. Functional alteration of granulocytes, NK cells, and natural killer T cells in centenarians. Hum Immunol 2000 61 908-916
42. Poynter M E., Mu H H., Chen X P., Daynes R A. Activation of NK1.1+T cells in vitro and their possible role in age-associated changes in inducible IL-4 production. Cell Immunol 1997 179 22-29
43. Dubey D P., Husain Z, Levitan E et al. The MHC influences NK and NKT cell functions associated with immune abnormalities and lifespan. Mech Ageing Dev 2000 113 117-134
44. Flurkey K, Stadecker M, Miller R A. Memory T lymphocyte hyporesponsiveness to non-cognate stimuli: a key factor in age-related immunodeficiency. Eur J Immunol 1992 22 931-935
45. Naylor K, Li G, Vallejo A N. et al. The influence of age on T cell generation and TCR diversity. J Immunol 2005 174 7446-7452
46. Swain S, Clise-Dwyer K, Haynes L. Homeostasis and the age-associated defect of CD4 T cells. Semin Immunol 2005 17 370-377
47. Cakman I, Rohwer J, Schütz R M., Kirchner H, Rink L. Dysregulation between TH1 and TH2 T cell subpopulations in the elderly. Mech Ageing Dev 1996 87 197-209
48. Zhou T, Edwards C K. III, Mountz J D. Prevention of age-related T cell apoptosis defect in CD2-fas-transgenic mice. J Exp Med 1995 182 129-137
49. Jackola D R., Ruger J K., Miller R A. Age-associated changes in human T cell phenotype and function. Aging (Milano) 1994 6 25-34
50. McKenna R W., Washington L T., Aquino D B., Picker L J., Kroft S H. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry. Blood 2001 98 2498-2507
51. Dailey R W., Eun S Y., Russell C E., Vogel L A. B cells of aged mice show decreased expansion in response to antigen, but are normal in effector function. Cell Immunol 2001 214 99-109
52. Doria G, D'Agostaro G, Poretti A. Age-dependent variations of antibody avidity. Immunology 1978 35 601-611
53. Yang X, Stedra J, Cerny J. Relative contribution of T and B cells to hypermutation and selection of the antibody repertoire in germinal centers of aged mice. J Exp Med 1996 183 959-970
54. Ferguson F G., Wikby A, Maxson P, Olsson J, Johansson B. Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors. J Gerontol A Biol Sci Med Sci 1995 50 B378-B382
55. Butcher S K., Lord J M. Stress responses and innate immunity: aging as a contributory factor. Aging Cell 2004 3 151-160
56. Verbeken E K., Cauberghs M, Mertens I, Clement J, Lauweryns J M., Van de Woestijne K P. The senile lung: comparison with normal and emphysematous lungs. 1. Structural aspects. Chest 1992 101 793-799
57. Fishman A P. One hundred years of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005 171 941-948
58. Mittman C, Edelman N H., Norris A H., Shock N W. Relationship between chest wall and pulmonary compliance and age. J Appl Physiol 1965 20 1211-1216
59. Turner J M., Mead J, Wohl M E. Elasticity of human lungs in relation to age. J Appl Physiol 1968 25 664-671
60. Hancock D B., Eijgelsheim M, Wilk J B. et al. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet 2010 42 45-52
61. Edge J R., Millard F J., Reid L, Simon G. The radiographic appearances of the chest in persons of advanced age. Br J Radiol 1964 37 769-774
62. Tolep K, Kelsen S G. Effect of aging on respiratory skeletal muscles. Clin Chest Med 1993 14 363-378
63. Polkey M I., Harris M L., Hughes P D. et al. The contractile properties of the elderly human diaphragm. Am J Respir Crit Care Med 1997 155 1560-1564
64. Evans S A., Watson L, Hawkins M, Cowley A J., Johnston I D., Kinnear W J. Respiratory muscle strength in chronic heart failure. Thorax 1995 50 625-628
65. Mancini D M., Henson D, LaManca J, Levine S. Respiratory muscle function and dyspnea in patients with chronic congestive heart failure. Circulation 1992 86 909-918
66. Verdery R B. Malnutrition and chronic inflammation: causes or effects of frailty. Aging Clin Exp Res 1992 4 262-263
67. Shaker R, Ren J L., Bardan E et al. Pharyngoglottal closure reflex: characterization in healthy young, elderly and dysphagic patients with predeglutitive aspiration. Gerontology 2003 49 12-20
68. Nakayama K, Jia Y X., Hirai H et al. Acid stimulation reduces bactericidal activity of surface liquid in cultured human airway epithelial cells. Am J Respir Cell Mol Biol 2002 26 105-113
69. Chouinard J. Dysphagia in Alzheimer disease: a review. J Nutr Health Aging 2000 4 214-217
70. Ruiz M, Ewig S, Marcos M A. et al. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med 1999 160 397-405
71. Puchelle E, Zahm J M., Bertrand A. Influence of age on bronchial mucociliary transport. Scand J Respir Dis 1979 60 307-313
72. Ho J C., Chan K N., Hu W H. et al. The effect of aging on nasal mucociliary clearance, beat frequency, and ultrastructure of respiratory cilia. Am J Respir Crit Care Med 2001 163 983-988
73. Plowden J, Renshaw-Hoelscher M, Engleman C, Katz J, Sambhara S. Innate immunity in aging: impact on macrophage function. Aging Cell 2004 3 161-167
74. Koike E, Kobayashi T, Mochitate K, Murakami M. Effect of aging on nitric oxide production by rat alveolar macrophages. Exp Gerontol 1999 34 889-894
75. Corsini E, Battaini F, Lucchi L et al. A defective protein kinase C anchoring system underlying age-associated impairment in TNF-alpha production in rat macrophages. J Immunol 1999 163 3468-3473
76. Zissel G, Schlaak M, Müller-Quernheim J. Age-related decrease in accessory cell function of human alveolar macrophages. J Investig Med 1999 47 51-56
77. Corsini E, Di Paola R, Viviani B et al. Increased carrageenan-induced acute lung inflammation in old rats. Immunology 2005 115 253-261
78. Ito K, Barnes P J. COPD as a disease of accelerated lung aging. Chest 2009 135 173-180
79. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977 1 1645-1648
80. Harman D. Free radical theory of aging: an update: increasing the functional life span. Ann N Y Acad Sci 2006 1067 10-21
81. Promislow D E. DNA repair and the evolution of longevity: a critical analysis. J Theor Biol 1994 170 291-300
82. Gupte A A., Bomhoff G L., Geiger P C. Age-related differences in skeletal muscle insulin signaling: the role of stress kinases and heat shock proteins. J Appl Physiol 2008 105 839-848
83. Rahman I, Adcock I M. Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J 2006 28 219-242
84. Ito K. Does lung aging have an impact on chronic obstructive pulmonary disease? J Organ Dysfunction 2007 3 204-220
85. Grubisha O, Smith B C., Denu J M. Small molecule regulation of Sir2 protein deacetylases. FEBS J 2005 272 4607-4616
86. Suga T, Kurabayashi M, Sando Y et al. Disruption of the klotho gene causes pulmonary emphysema in mice: defect in maintenance of pulmonary integrity during postnatal life. Am J Respir Cell Mol Biol 2000 22 26-33
87. Maruyama N, Ishigami A, Kuramoto M et al. Senescence marker protein-30 knockout mouse as an aging model. Ann N Y Acad Sci 2004 1019 383-387
88. Vogel H, Lim D S., Karsenty G, Finegold M, Hasty P. Deletion of Ku86 causes early onset of senescence in mice. Proc Natl Acad Sci U S A 1999 96 10770-10775
89. Sato T, Seyama K, Sato Y et al. Senescence marker protein-30 protects mice lungs from oxidative stress, aging, and smoking. Am J Respir Crit Care Med 2006 174 530-537
90. Collins K, Mitchell J R. Telomerase in the human organism. Oncogene 2002 21 564-579
91. Jiang H, Ju Z, Rudolph K L. Telomere shortening and ageing. Z Gerontol Geriatr 2007 40 314-324
92. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci 2002 27 339-344
93. Tsuji T, Aoshiba K, Nagai A. Alveolar cell senescence in patients with pulmonary emphysema. Am J Respir Crit Care Med 2006 174 886-893
94. Morlá M, Busquets X, Pons J, Sauleda J, MacNee W, Agustí A G. Telomere shortening in smokers with and without COPD. Eur Respir J 2006 27 525-528
95. Garcia C K., Wright W E., Shay J W. Human diseases of telomerase dysfunction: insights into tissue aging. Nucleic Acids Res 2007 35 7406-7416
96. Alder J K., Chen J J., Lancaster L et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci U S A 2008 105 13051-13056
97. Tsakiri K D., Cronkhite J T., Kuan P J. et al. Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc Natl Acad Sci U S A 2007 104 7552-7557
98. Hogg J C., van Eeden S. Pulmonary and systemic response to atmospheric pollution. Respirology 2009 14 336-346
99. Oberdörster G. Pulmonary effects of inhaled ultrafine particles. Int Arch Occup Environ Health 2001 74 1-8
100. Neupane B, Jerrett M, Burnett R T., Marrie T, Arain A, Loeb M. Long-term exposure to ambient air pollution and risk of hospitalization with community-acquired pneumonia in older adults. Am J Respir Crit Care Med 2010 181 47-53
101. Zanobetti A, Bind M A., Schwartz J. Particulate air pollution and survival in a COPD cohort. Environ Health 2008 7 48
102. Mora A L., Rojas M. Aging and lung injury repair: a role for bone marrow derived mesenchymal stem cells. J Cell Biochem 2008 105 641-647
103. Ruzankina Y, Asare A, Brown E J. Replicative stress, stem cells and aging. Mech Ageing Dev 2008 129 460-466
104. Butcher S K., Lord J M. Stress responses and innate immunity: aging as a contributory factor. Aging Cell 2004 3 151-160
105. Goncharova N D., Lapin B A. Age-related endocrine dysfunction in nonhuman primates. Ann N Y Acad Sci 2004 1019 321-325
106. Grimble R F. Inflammatory response in the elderly. Curr Opin Clin Nutr Metab Care 2003 6 21-29
107. Barnes P J. Corticosteroid resistance in airway disease. Proc Am Thorac Soc 2004 1 264-268
108. Lages C S., Suffia I, Velilla P A. et al. Functional regulatory T cells accumulate in aged hosts and promote chronic infectious disease reactivation. J Immunol 2008 181 1835-1848
109. Weyand C M., Brandes J C., Schmidt D, Fulbright J W., Goronzy J J. Functional properties of CD4+CD28T cells in the aging immune system. Mech Ageing Dev 1998 102 131-147
110. Bryl E, Vallejo A N., Weyand C M., Goronzy J J. Down-regulation of CD28 expression by TNF-alpha. J Immunol 2001 167 3231-3238
111. Gilani S R., Vuga L J., Lindell K O. et al. CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis. PLoS One 2010 5 e8959
112. Zalacain R, Torres A. Pneumonia in the elderly. Clin Pulm Med 2004 11 210-218
113. Treanor J, Falsey A. Respiratory viral infections in the elderly. Antiviral Res 1999 44 79-102
114. Metlay J P., Schulz R, Li Y H. et al. Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med 1997 157 1453-1459
115. Niederman M S., Mandell L A., Anzueto A et al, American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001 163 1730-1754
116. Fine M J., Auble T E., Yealy D M. et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997 336 243-250
117. Meehan T P., Fine M J., Krumholz H M. et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 1997 278 2080-2084
118. Falsey A R., Walsh E E. Viral pneumonia in older adults. Clin Infect Dis 2006 42 518-524
119. Thompson W W., Shay D K., Weintraub E et al. Influenza-associated hospitalizations in the United States. JAMA 2004 292 1333-1340
120. Bradley S F., Long-Term-Care Committee of the Society for Healthcare Epidemiology of America. Prevention of influenza in long-term-care facilities. Infect Control Hosp Epidemiol 1999 20 629-637
121. Falsey A R., Hennessey P A., Formica M A., Cox C, Walsh E E. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 2005 352 1749-1759
122. Looney R J., Falsey A R., Walsh E, Campbell D. Effect of aging on cytokine production in response to respiratory syncytial virus infection. J Infect Dis 2002 185 682-685
123. Hicks L A., Shepard C W., Britz P H. et al. Two outbreaks of severe respiratory disease in nursing homes associated with rhinovirus. J Am Geriatr Soc 2006 54 284-289
124. Louie J K., Yagi S, Nelson F A. et al. Rhinovirus outbreak in a long term care facility for elderly persons associated with unusually high mortality. Clin Infect Dis 2005 41 262-265
125. Mosser A G., Vrtis R, Burchell L et al. Quantitative and qualitative analysis of rhinovirus infection in bronchial tissues. Am J Respir Crit Care Med 2005 171 645-651
126. Laforce F M., Hopkins J, Trow R, Wang W L. Human oral defenses against gram-negative rods. Am Rev Respir Dis 1976 114 929-935
127. Smaldone G C. Deposition and clearance: unique problems in the proximal airways and oral cavity in the young and elderly. Respir Physiol 2001 128 33-38
128. Palmer L B., Albulak K, Fields S, Filkin A M., Simon S, Smaldone G C. Oral clearance and pathogenic oropharyngeal colonization in the elderly. Am J Respir Crit Care Med 2001 164 464-468
129. Ayars G H., Altman L C., Fretwell M D. Effect of decreased salivation and pH on the adherence of Klebsiella species to human buccal epithelial cells. Infect Immun 1982 38 179-182
130. Kikuchi R, Watabe N, Konno T, Mishina N, Sekizawa K, Sasaki H. High incidence of silent aspiration in elderly patients with community-acquired pneumonia. Am J Respir Crit Care Med 1994 150 251-253
131. Matsuse T, Oka T, Kida K, Fukuchi Y. Importance of diffuse aspiration bronchiolitis caused by chronic occult aspiration in the elderly. Chest 1996 110 1289-1293
132. Nakayama K, Jia Y X., Hirai H et al. Acid stimulation reduces bactericidal activity of surface liquid in cultured human airway epithelial cells. Am J Respir Cell Mol Biol 2002 26 105-113
133. Riquelme R, Torres A, El-Ebiary M et al. Community-acquired pneumonia in the elderly: a multivariate analysis of risk and prognostic factors. Am J Respir Crit Care Med 1996 154 1450-1455
134. Lesourd B M. Nutrition: a major factor influencing immunity in the elderly. J Nutr Health Aging 2004 8 28-37
135. Yeh S S., Schuster M W. Geriatric cachexia: the role of cytokines. Am J Clin Nutr 1999 70 183-197
136. Pamuk E R., Williamson D F., Serdula M K., Madans J, Byers T E. Weight loss and subsequent death in a cohort of U.S. adults. Ann Intern Med 1993 119 (7 Pt 2) 744-748
137. Maffei M, Halaas J, Ravussin E et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995 1 1155-1161
138. Mancuso P, Gottschalk A, Phare S M., Peters-Golden M, Lukacs N W., Huffnagle G B. Leptin-deficient mice exhibit impaired host defense in gram-negative pneumonia. J Immunol 2002 168 4018-4024
139. Ernst P, Gonzalez A V., Brassard P, Suissa S. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. Am J Respir Crit Care Med 2007 176 162-166
140. Calverley P M., Anderson J A., Celli B et al, TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007 356 775-789
141. Sin D D., Tashkin D, Zhang X et al. Budesonide and the risk of pneumonia: a meta-analysis of individual patient data. Lancet 2009 374 712-719
142. Welte T. Inhaled corticosteroids in COPD and the risk of pneumonia. Lancet 2009 374 668-670
143. Eurich D T., Sadowski C A., Simpson S H., Marrie T J., Majumdar S R. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs. Am J Med 2010 123 47-53
144. Laheij R J., Sturkenboom M C., Hassing R J., Dieleman J, Stricker B H., Jansen J B. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 2004 292 1955-1960
145. Sarkar M, Hennessy S, Yang Y X. Proton-pump inhibitor use and the risk for community-acquired pneumonia. Ann Intern Med 2008 149 391-398
146. Bartlett J G., Mundy L M. Community-acquired pneumonia. N Engl J Med 1995 333 1618-1624
147. Rossman J S., Lamb R A. Swine-origin influenza virus and the 2009 pandemic. Am J Respir Crit Care Med 2010 181 295-296
148. Reed C, Angulo F J., Swerdlow D L. et al. Estimates of the prevalence of pandemic (H1N1) 2009, United States, AprilJuly 2009. Emerg Infect Dis 2009 15 2004-2007
149. Louie J K., Acosta M, Winter K et al, California Pandemic (H1N1) Working Group. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009 302 1896-1902
150. Ciancio B C., Meerhoff T J., Kramarz P et al. Oseltamivir-resistant influenza A(H1N1) viruses detected in Europe during season 20078 had epidemiologic and clinical characteristics similar to co-circulating susceptible A(H1N1) viruses. Euro Surveill 2009 14 (46). pii 19412
151. Fagiolo U, Amadori A, Cozzi E et al. Humoral and cellular immune response to influenza virus vaccination in aged humans. Aging (Milano) 1993 5 451-458
152. Artz A S., Ershler W B., Longo D L. Pneumococcal vaccination and revaccination of older adults. Clin Microbiol Rev 2003 16 308-318
153. Gross P A., Hermogenes A W., Sacks H S., Lau J, Levandowski R A. The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Ann Intern Med 1995 123 518-527
154. Sisk J E., Moskowitz A J., Whang W et al. Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people. JAMA 1997 278 1333-1339
155. Butler J C., Breiman R F., Campbell J F., Lipman H B., Broome C V., Facklam R R. Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations. JAMA 1993 270 1826-1831
156. Simberkoff M S., Cross A P., Al-Ibrahim M et al. Efficacy of pneumococcal vaccine in high-risk patients: results of a Veterans Administration Cooperative Study. N Engl J Med 1986 315 1318-1327
157. Ortqvist A. Pneumococcal vaccination: current and future issues. Eur Respir J 2001 18 184-195
158. Dear K, Holden J, Andrews R, Tatham D. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2003 (4) CD000422
159. Evans S E., Scott B L., Clement C G. et al. Stimulated innate resistance of lung epithelium protects mice broadly against bacteria and fungi. Am J Respir Cell Mol Biol 2010 42 40-50
160. Nichol K L., Margolis K L., Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994 331 778-784
161. Ghendon Y Z., Kaira A N., Elshina G A. The effect of mass influenza immunization in children on the morbidity of the unvaccinated elderly. Epidemiol Infect 2006 134 71-78
162. Reichert T A., Sugaya N, Fedson D S., Glezen W P., Simonsen L, Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 2001 344 889-896
163. Centers for Disease Control and Prevention (CDC). Interim results: influenza A (H1N1) 2009 monovalent vaccination coverage: United States, OctoberDecember 2009. MMWR Morb Mortal Wkly Rep 2010 59 44-48